Cognition Therapeutics to Report Second Quarter 2023 Results in Conference Call on Tuesday, August 8, 2023 - Cognition Therapeutics (NASDAQ:CGTX)

PURCHASE, N.Y., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical-stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular damage

Related Keywords

Daniel Kontoh Boateng ,Aline Sherwood ,Cognition Therapeutics Inc ,Company Or Cognition ,Tiberend Strategic Advisors Inc ,Scienta Communications ,Securities Exchange Commission ,Call Information ,Cognition Therapeutics ,Private Securities Litigation Reform Act ,Securities Exchange ,Strategic Advisors ,